Hereditary Testing Market Size, Share & Trends Analysis Report By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 08, 2026 | Author: Debashree B | Format: | Report Code: SRMD2280DR | Pages: 156

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends

  8. Global Hereditary Testing Market Size Analysis
    1. Global Hereditary Testing Market Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. U.S.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. U.K.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Germany
    5. France
    6. Spain
    7. Italy
    8. Russia
    9. Nordic
    10. Benelux
    11. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. China
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Korea
    5. Japan
    6. India
    7. Australia
    8. Taiwan
    9. South East Asia
    10. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. UAE
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Turkey
    5. Saudi Arabia
    6. South Africa
    7. Egypt
    8. Nigeria
    9. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. Brazil
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Mexico
    5. Argentina
    6. Chile
    7. Colombia
    8. Rest of LATAM
  14. Competitive Landscape
    1. Hereditary Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Myriad Genetics Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina Inc.
    3. Natera Inc.
    4. Invitae Corporation
    5. Laboratory Corporation of America Holdings
    6. Quest Diagnostics Incorporated
    7. F. Hoffmann-La Roche Ltd.
    8. COOPERSURGICAL INC.
    9. Agilent Technologies Inc.
    10. Thermo Fisher Scientific Inc.
    11. SOPHiA GENETICS
    12. Fulgent Genetics
    13. Twist Bioscience
    14. MedGenome
    15. CENTOGENE N.V.
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on: